• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION AGENT; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION AGENT; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 3825
Device Problem Break (1069)
Patient Problem No Patient Involvement (2645)
Event Date 12/25/2019
Event Type  malfunction  
Manufacturer Narrative
Device is a combination product.
 
Event Description
It was reported that a shaft break occurred.A percutaneous coronary intervention was being performed.Vascular access was obtained via the right radial artery.The target lesion was located in the non tortuous and non calcified, eccentric, de novo lesion in the left circumflex coronary artery.A 2.75 mm x 15.00mm agent drug-coated balloon was advanced into the guide catheter where the balloon shaft broke.The procedure was successfully completed with a different device without issue or patient injury.
 
Manufacturer Narrative
Device is a combination product.The outer shaft, inner shaft, balloon and tip were visually and microscopically examined.Visual examination revealed that the hypotube was separated 54.8cm from the hub.There were multiple kinks along the hypotube.Microscopic examination revealed no additional damages.Inspection of the remainder of the device presented no other damage or irregularities.Product analysis confirmed the hypotube was separated but appeared to have been kinked prior to separation.
 
Event Description
It was reported that a shaft break occurred.A percutaneous coronary intervention was being performed.Vascular access was obtained via the right radial artery.The target lesion was located in the non tortuous and non calcified, eccentric, de novo lesion in the left circumflex coronary artery.A 2.75 mm x 15.00mm agent drug-coated balloon was advanced into the guide catheter where the balloon shaft broke.The procedure was successfully completed with a different device without issue or patient injury.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AGENT
Type of Device
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key9574304
MDR Text Key178014979
Report Number2134265-2019-16342
Device Sequence Number1
Product Code LOX
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 02/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/10/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/23/2020
Device Model Number3825
Device Catalogue Number3825
Device Lot Number8544H18
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/22/2020
Date Manufacturer Received01/28/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age68 YR
-
-